Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Not So Special? FDA Proposal Would Damage Streamlined 510(k) Submissions Program, Firms Say

This article was originally published in The Gray Sheet

Executive Summary

Agency’s proposed “special 510(k)” reforms, outlined in a recent draft guidance, will make the streamlined submissions program a lot less streamlined, and also less accessible to many device modifications, companies say.


Related Content

Proposed 510(k) Changes Elicit Some Industry Skepticism
FDA Looks To Expand Special 510(k) Program
Paradigm Persists: FDA Finalizes 510(k) Guidance Without Special 510(k) Changes
510(k) Program, Companion Dx Among Top FDA Guidance Priorities For FY 2014
510(k) Guidance Footnote May Signal Greater FDA Oversight Of Preclinical Testing
Changing The Paradigm: 510(k) Draft Guidance May Raise New Questions
New Guidance Will Clarify Which Devices Aren't Eligible For Simpler 510(k)s





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts